3D-QSAR AND MOLECULAR DOCKING OF INDOLO[3,2-C] QUINOLONE ANALOGUES FOR ANTIPLASMODIAL ACTIVITY
Main Article Content
Keywords
QSAR, CoMFA, CoMSIA, HQSAR, in silico virtual screening, β-haematin inhibitory activity, antiplasmodiam activity.
Abstract
As per the 2020 World Malaria Report, an approximate of 429000 fatalities worldwide were attributed to malaria. In order to treat the various underlying deficiencies of the pathology of malaria and to overcome the limitations of monotherapy, contemporary medications are being utilized as useful adjuncts to dietary therapeutic strategies, either alone or in combination. In recent times, heterocyclic compounds have become increasingly significant due to their pharmacological properties. in silico virtual screening and molecular docking are valuable techniques in drug discovery and development. These methods leverage computational approaches to analyze and predict the interactions between small molecules (ligands) and biological macromolecules, such as proteins .As a result, this research effort uses a contemporary in silico virtual screening technique to prioritize unique One hundred twenty-five compounds were proposed as antimalarials based on the reported structure-activity relationship of Indolo[3,2-c] quinolone analogues as well as QSAR research using CoMFA, CoMSIA, HQSAR, and Molecular modeling (Docking) studies. To get more models, QSAR research have also been carried out. The time, money, and human resources required to get the medication to patients are reduced by QSAR.
Downloads
References
1. Gurarie D, Zimmerman PA, King CH. Dynamic regulation of single-and mixed-species malaria infection: insights to specific and non-specific mechanisms of control. Journal of theoretical biology. 2006 May 21;240(2):185-99. 2. Mayxay M, Pukrittayakamee S, Newton PN, White NJ. Mixed-species malaria infections in humans. Trends in parasitology. 2004 May 1;20(5):233-40. 3. Zimmerman PA, Mehlotra RK, Kasehagen LJ, Kazura JW. Why do we need to know more about mixed Plasmodium species infections in humans?. Trends in parasitology. 2004 Sep 1;20(9):440-7. 4. WHO 2016, World Malaria report.10-17. Antimalarial Programme. Geneva, Switzerland. 5. Ndakala AJ, Gessner RK, Gitari PW, October N, White KL, Hudson A, Fakorede F, Shackleford DM, Kaiser M, Yeates C, Charman SA. Antimalarial Pyrido [1, 2-a] benzimidazoles. Journal of medicinal chemistry. 2011 Jul 14;54(13):4581-9. 6. Torres-Gómez H, Hernández-Núñez E, León-Rivera I, Guerrero-Alvarez J, Cedillo-Rivera R, Moo-Puc R, Argotte-Ramos R, del Carmen Rodríguez-Gutiérrez M, Chan-Bacab MJ, Navarrete-Vázquez G. Design, synthesis and in vitro antiprotozoal activity of benzimidazole-pentamidine hybrids. Bioorganic & medicinal chemistry letters. 2008 Jun 1;18(11):3147-51. 7. Young DC. A practical guide for applying techniques to real-world problems. Computational Chemistry, New York. 2001;9:390. 8. Mai A, Sbardella G, Artico M, Ragno R, Massa S, Novellino E, Greco G, Lavecchia A, Musiu C, La Colla M, Murgioni C. Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2, 6-difluorophenyl) alkyl]-3, 4-dihydro-5-alkylpyrimidin-4 (3 H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Journal of medicinal chemistry. 2001 Aug 2;44(16):2544-54. 9. Sharma MC, Smita Sharma SS. 2D Qsar study of 7-methyljuglone derivatives: an approach to design anti tubercular agents. 10. Hansch C, Leo AJ. Substituent constants for correlation analysis in chemistry and biology Wiley. New York, ISBN. 1979;10:0471050628. 11. Kubinyi H. QSAR: Hansch analysis and related approaches. Weinheim: VcH; 1993 Oct 28. 12. Malamas MS, Robichaud A, Erdei J, Quagliato D, Solvibile W, Zhou P, Turner J, Wagner E, Fan K, Olland A, Jacobsen S. Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability. Bioorganic & medicinal chemistry letters. 2010 Nov 15;20(22):6597-605. 13. Catana C, Stouten PF. Novel, customizable scoring functions, parameterized using N-PLS, for structure-based drug discovery. Journal of chemical information and modeling. 2007 Jan 22;47(1):85-91. 14. Introduction to Molegro Virtual Docker, user manual MVD 2008.3.0 for Windows (www.molegro.com). 15. Roy D, Anas M, Manhas A, Saha S, Kumar N, Panda G. Synthesis, biological evaluation, Structure− Activity relationship studies of quinoline-imidazole derivatives as potent antimalarial agents. Bioorganic Chemistry. 2022 Apr 1;121:105671. 16. Irabuena C, Scarone L, de Souza GE, Aguiar AC, Mendes GR, Guido RV, Serra G. Synthesis and antiplasmodial assessment of nitazoxanide and analogs as new antimalarial candidates. Medicinal Chemistry Research. 2022 Mar;31(3):426-35. 17. Håheim KS, Lindbäck E, Tan KN, Albrigtsen M, Urdal Helgeland IT, Lauga C, Matringe T, Kennedy EK, Andersen JH, Avery VM, Sydnes MO. Synthesis and Evaluation of the Tetracyclic Ring-System of Isocryptolepine and Regioisomers for Antimalarial, Antiproliferative and Antimicrobial Activities. Molecules. 2021 May 30;26(11):3268. 18. Rodphon W, Laohapaisan P, Supantanapong N, Reamtong O, Ngiwsara L, Lirdprapamongkol K, Thongsornkleeb C, Khunnawutmanotham N, Tummatorn J, Svasti J, Ruchirawat S. Synthesis of Isocryptolepine‐Triazole Adducts and Evaluation of Their Cytotoxic Activity. ChemMedChem. 2021 Dec 14;16(24):3750-62. 19. Akitake M, Noda S, Miyoshi K, Sonoda M, Tanimori S. Access to γ-Carbolines: Synthesis of Isocryptolepine. The Journal of Organic Chemistry. 2021 Dec 6;86(24):17727-37. 20. Eagon S, Hammill JT, Fitzsimmons K, Sienko N, Nguyen B, Law J, Manjunath A, Wilkinson SP, Thompson K, Glidden JE, Rice AL. Antimalarial activity of 2, 6-dibenzylidenecyclohexanone derivatives. Bioorganic & Medicinal Chemistry Letters. 2021 Sep 1;47:128216.
